We have developed an automated method for measuring high-density lipoprotein (HDL)-cholesterol in serum without prior separation, using polyethylene glycol (PEG)-modified enzymes and sulfated a-cyclodextrin. When cholesterol esterase and cholesterol oxidase enzymes were modffied with PEG, they showed selective catalytic activities towards lipoprotein fractions, with the reactivity increasing in the order: low-density lipoprotein < verylow-density lipoprotein chylomicron < HDL. In the presence of magnesium ions, a-cyclodextrin sulfate reduced the reactivity of cholesterol, especially in chylomicrons and very-low-density lipoprotein, without the need 
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Analytical Procedure
In the final format, reagent 1 was composed of a-cyclodextrin sulfate (0.5 mmoIJL), dextran sulfate and a tiV 160 A spectrophotometer (Shimadzu, Kyoto, Japan) were used for the measurement.
Results

Characteristics of PEG-Modified Enzymes
To minimize the loss of intrinsic activities of both enzymes, we used the higher molecular-mass forms of PEG, PEG 6000 and 12 000, instead of all other commercially available PEG preparations, which fail to penetrate the interior of the enzymes and thus may not react with the interior amino groups buried near the catalytic site of the enzymes (17) .
Because of the difficulty in removing unreacted
PEG 12000 from the reaction mixture, due to its high viscosity, we chose PEG 6000 as the suitable coupling agent for CHER and CHOD. The PEG-CHER preparations with different degrees of modification were made by varying the amount of activated PEG added to the enzyme solution, and their selectivities toward HDL-cholesterol were compared ( Table 2 ). The relative reactivity of cholesterol with the modified enzyme in each lipoprotein fraction was expressed as a percentage of the native enzyme activity.
With increasing degree of modification, the selectivity of the PEG-CHER to HDL-cholesterol was also increased and reached a maximum when 40% of the amino groups in the enzyme were coupled to PEG. In the same way, the PEG-CHOD, with a degree of modification of -40%, exhibited the desired characteristics.
We therefore used preparations of only -25% of the LDL-cholesterol was reactive with 1 kU/L PEG-CHER.
On the other hand, when the activated PEG was present at the same concentrations as those used with the modified enzyme, the reactivity of the LDL-cholesterol with the native enzyme was not decreased. the modified enzymes are shown in Fig. 4 . When the pH of the medium was adjusted to 7, the relative reactivity of HDL-cholesterol was nearly unaffected, whereas those of the other lipoprotein-cholesterols were decreased significantly.
Effect of a-Cyclodextrin Sulfate on Lipoprotein Fractions
In our preliminary studies, an extent that it interfered with the determination of the HDL-cholesterol in serum.
Calibration Curve and Linearity
The HDL fraction (HDL-cholesterol; 1600 mgfL) isolated by ultracentrifugation was diluted with 9 gIL NaCl solution and used for the linearity study. As shown in Fig. 7 , the assay results of the serially diluted fractions of HDL-cholesterol solution showed excellent linearity up to -1500 mg/L, with a lower detection limit of 2.5 mg/L. The concentration of HDL-cholesterol was also determined conveniently after assay calibration with a calibrator serum (520 mgfL Liquichek Lipids Control; Bio-Rad). Good linearity and reproducibility were obtained with different lots of the modified enzymes and a-cyclodextrin sulfate.
Precision and Recovery
Within-run imprecision (CV) of the HDL-cholestero! assay was, respectively, 1.98%, 0.59%, and 0.59% at 200, 530, and 1050 mg/L HDL-cholesterol solutions in pooled sera. The between-assay CV was <3.2% as determined by assaying the same sample on 10 different days.
Recovery studies were performed after adding known amounts of HDL-cholesterol calibrator dissolved in pooled serum (360-860 mgfL) to a serum sample before assay. Recoveries of 99-103% were achieved in random serum samples.
Interference Studies
Addition of bilirubin (<400 mg/L) to the pooled serum produced a slight negative error (<10%) in the assay result. No such interference was observed when either hemoglobin, ascorbic acid, sugars, citrate, EDTA-Na2, or heparin was included during the measurement of HDL-cholesterol with this assay.
Methods Comparison
We compared the results obtained by our method (y) with those of a dextran sulfate-phosphotungstate- MgCl2 precipitation method (x) (20) with 57 serum samples from healthy volunteers and 120 samples from hyperlipemic patients containing high serum triglyceride concentrations ranging from 2 to 20 g/L (Fig. 8) .
When the results of our assay were compared with those of the other precipitation-based methods and that of an ultracentrifugation method, for serum samples from patients with hyperlipemia, the observed correlations were excellent (Table 4) .
Reference Range
The In conclusion, the method described here is simple and reliable for measuring HDL-cholesterol in serum without the need for prior separation of other fractions and has the potential as a first-line test to monitor HDL-cholesterol in serum.
